eligibility for clinicaltrials:NCT00136006 [clinicaltrials_resource:7a7f0c2f7686ac4d5f1e29e85c61c416]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT00136006 [clinicaltrials_resource:7a7f0c2f7686ac4d5f1e29e85c61c416]
Bio2RDF identifier
7a7f0c2f7686ac4d5f1e29e85c61c416
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7a7f0c2f7686ac4d5f1e29e85c61c416
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
maximum age [clinicaltrials_vocabulary:maximum-age]
minimum age [clinicaltrials_vocabulary:minimum-age]
study population [clinicaltrials_vocabulary:study-population]
Population of Vancouver, BC, Canada
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... ious life threatening illness.
identifier
clinicaltrials_resource:7a7f0c2f7686ac4d5f1e29e85c61c416
title
eligibility for clinicaltrials:NCT00136006
@en
type
label
eligibility for clinicaltrials ...... f0c2f7686ac4d5f1e29e85c61c416]
@en